NAGLAZYME

Serial Number 78819328
Registration 3193328
800

Registration Progress

Application Filed
Feb 21, 2006
Under Examination
Approved for Publication
Sep 27, 2006
Published for Opposition
Oct 17, 2006
Registered
Jan 2, 2007

Trademark Image

NAGLAZYME

Basic Information

Serial Number
78819328
Registration Number
3193328
Filing Date
February 21, 2006
Registration Date
January 2, 2007
Published for Opposition
October 17, 2006
Renewal Date
January 2, 2017
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
800
Status Date
Jul 21, 2016
Registration
Registered
Classes
005

Rights Holder

BioMarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

BioMarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

BioMarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

BioMarin Pharmaceutical Inc.

Original Registrant
03
Novato, CA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

Next Deadline
537 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-01-02)
Due Date
January 02, 2027
Grace Period Ends
July 02, 2027

Application History

23 events
Date Code Type Description
Jul 21, 2016 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 21, 2016 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 21, 2016 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 18, 2016 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jun 8, 2016 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Jun 6, 2016 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 26, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 26, 2016 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Feb 17, 2016 E89R I TEAS SECTION 8 & 9 RECEIVED
Jan 2, 2016 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 4, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 4, 2012 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 4, 2012 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 6, 2012 E815 I TEAS SECTION 8 & 15 RECEIVED
Jan 2, 2007 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 17, 2006 PUBO A PUBLISHED FOR OPPOSITION
Sep 27, 2006 NPUB O NOTICE OF PUBLICATION
Aug 26, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 18, 2006 ALIE A ASSIGNED TO LIE
Aug 11, 2006 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2006 DOCK D ASSIGNED TO EXAMINER
Mar 1, 2006 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED
Feb 28, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM

Detailed Classifications

Class 005
Pharmaceutical preparations, namely pharmaceuticals for use in treatment of lysosomal storage disorders
First Use Anywhere: Jun 8, 2005
First Use in Commerce: Jun 8, 2005

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...